The estimated Net Worth of Carol Walker is at least $7.95 Millón dollars as of 30 March 2022. Ms. Walker owns over 15,000 units of Lantheus Inc stock worth over $6,616,453 and over the last 3 years she sold LNTH stock worth over $1,337,948. In addition, she makes $0 as Senior Vice President - Quality at Lantheus Inc.
Carol has made over 4 trades of the Lantheus Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she sold 15,000 units of LNTH stock worth $843,300 on 30 March 2022.
The largest trade she's ever made was selling 15,000 units of Lantheus Inc stock on 30 March 2022 worth over $843,300. On average, Carol trades about 6,271 units every 7 days since 2022. As of 30 March 2022 she still owns at least 64,899 units of Lantheus Inc stock.
You can see the complete history of Ms. Walker stock trades at the bottom of the page.
Carol Walker serves as Senior Vice President - Quality of the Company since April 2018, having previously served as our as our Vice President, Quality since February 2015. Ms. Walker brings more than 30 years of industry experience in quality and medical technology primarily in the medical device area. Prior to joining Lantheus, Ms. Walker served as Vice President of Quality for Intelligent Medical Devices, Inc. from 2012 to 2015. Previously she held a number of successive Quality management roles at Siemens Healthcare Diagnostics (formerly Bayer Healthcare Diagnostics), including Vice President, Quality Assurance from 2007 to 2011 and Director, Quality Assurance from 2001 to 2007. Ms. Walker received a Bachelor of Science degree in Medical Technology from the Rochester Institute of Technology.
Carol Walker is 57, she's been the Senior Vice President - Quality of Lantheus Inc since 2018. There are 11 older and 14 younger executives at Lantheus Inc. The oldest executive at Lantheus Holdings Inc is James Thrall, 76, who is the Independent Director.
Carol's mailing address filed with the SEC is C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA, MA, 01862.
Over the last 9 years, insiders at Lantheus Inc have traded over $500,725,766 worth of Lantheus Inc stock and bought 8,000 units worth $141,200 . The most active insiders traders include David F Burgstahler, Capital Partners Gp, Llc Av... y Sriram Venkataraman. On average, Lantheus Inc executives and independent directors trade stock every 11 days with the average trade being worth of $15,777,680. The most recent stock trade was executed by James H Thrall on 21 August 2024, trading 1,000 units of LNTH stock currently worth $98,520.
lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.
Lantheus Inc executives and other stock owners filed with the SEC include: